Cargando…

Histologic and Histomorphometric Evaluation of a New Bioactive Liquid BBL on Implant Surface: A Preclinical Study in Foxhound Dogs

Background: Bioactive chemical surface modifications improve the wettability and osseointegration properties of titanium implants in both animals and humans. The objective of this animal study was to investigate and compare the bioreactivity characteristics of titanium implants (BLT) pre-treated wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrés-Amat, Eduard, Al Madhoun, Ashraf, Ferrés-Amat, Elvira, Al Demour, Saddam, Ababneh, Mera A., Ferrés-Padró, Eduard, Marti, Carles, Carrio, Neus, Barajas, Miguel, Atari, Maher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540508/
https://www.ncbi.nlm.nih.gov/pubmed/34683810
http://dx.doi.org/10.3390/ma14206217
_version_ 1784589003856543744
author Ferrés-Amat, Eduard
Al Madhoun, Ashraf
Ferrés-Amat, Elvira
Al Demour, Saddam
Ababneh, Mera A.
Ferrés-Padró, Eduard
Marti, Carles
Carrio, Neus
Barajas, Miguel
Atari, Maher
author_facet Ferrés-Amat, Eduard
Al Madhoun, Ashraf
Ferrés-Amat, Elvira
Al Demour, Saddam
Ababneh, Mera A.
Ferrés-Padró, Eduard
Marti, Carles
Carrio, Neus
Barajas, Miguel
Atari, Maher
author_sort Ferrés-Amat, Eduard
collection PubMed
description Background: Bioactive chemical surface modifications improve the wettability and osseointegration properties of titanium implants in both animals and humans. The objective of this animal study was to investigate and compare the bioreactivity characteristics of titanium implants (BLT) pre-treated with a novel bone bioactive liquid (BBL) and the commercially available BLT-SLA active. Methods: Forty BLT-SLA titanium implants were placed in in four foxhound dogs. Animals were divided into two groups (n = 20): test (BLT-SLA pre-treated with BBL) and control (BLT-SLA active) implants. The implants were inserted in the post extraction sockets. After 8 and 12 weeks, the animals were sacrificed, and mandibles were extracted, containing the implants and the surrounding soft and hard tissues. Bone-to-implant contact (BIC), inter-thread bone area percentage (ITBA), soft tissue, and crestal bone loss were evaluated by histology and histomorphometry. Results: All animals were healthy with no implant loss or inflammation symptoms. All implants were clinically and histologically osseo-integrated. Relative to control groups, test implants demonstrated a significant 1.5- and 1.7-fold increase in BIC and ITBA values, respectively, at both assessment intervals. Crestal bone loss was also significantly reduced in the test group, as compared with controls, at week 8 in both the buccal crests (0.47 ± 0.32 vs 0.98 ± 0.51 mm, p < 0.05) and lingual crests (0.39* ± 0.3 vs. 0.89 ± 0.41 mm, p < 0.05). At week 12, a pronounced crestal bone loss improvement was observed in the test group (buccal, 0.41 ± 0.29 mm and lingual, 0.54 ± 0.23 mm). Tissue thickness showed comparable values at both the buccal and lingual regions and was significantly improved in the studied groups (0.82–0.92 mm vs. 33–48 mm in the control group). Conclusions: Relative to the commercially available BLT-SLA active implants, BLT-SLA pre-treated with BBL showed improved histological and histomorphometric characteristics indicating a reduced titanium surface roughness and improved wettability, promoting healing and soft and hard tissue regeneration at the implant site.
format Online
Article
Text
id pubmed-8540508
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85405082021-10-24 Histologic and Histomorphometric Evaluation of a New Bioactive Liquid BBL on Implant Surface: A Preclinical Study in Foxhound Dogs Ferrés-Amat, Eduard Al Madhoun, Ashraf Ferrés-Amat, Elvira Al Demour, Saddam Ababneh, Mera A. Ferrés-Padró, Eduard Marti, Carles Carrio, Neus Barajas, Miguel Atari, Maher Materials (Basel) Article Background: Bioactive chemical surface modifications improve the wettability and osseointegration properties of titanium implants in both animals and humans. The objective of this animal study was to investigate and compare the bioreactivity characteristics of titanium implants (BLT) pre-treated with a novel bone bioactive liquid (BBL) and the commercially available BLT-SLA active. Methods: Forty BLT-SLA titanium implants were placed in in four foxhound dogs. Animals were divided into two groups (n = 20): test (BLT-SLA pre-treated with BBL) and control (BLT-SLA active) implants. The implants were inserted in the post extraction sockets. After 8 and 12 weeks, the animals were sacrificed, and mandibles were extracted, containing the implants and the surrounding soft and hard tissues. Bone-to-implant contact (BIC), inter-thread bone area percentage (ITBA), soft tissue, and crestal bone loss were evaluated by histology and histomorphometry. Results: All animals were healthy with no implant loss or inflammation symptoms. All implants were clinically and histologically osseo-integrated. Relative to control groups, test implants demonstrated a significant 1.5- and 1.7-fold increase in BIC and ITBA values, respectively, at both assessment intervals. Crestal bone loss was also significantly reduced in the test group, as compared with controls, at week 8 in both the buccal crests (0.47 ± 0.32 vs 0.98 ± 0.51 mm, p < 0.05) and lingual crests (0.39* ± 0.3 vs. 0.89 ± 0.41 mm, p < 0.05). At week 12, a pronounced crestal bone loss improvement was observed in the test group (buccal, 0.41 ± 0.29 mm and lingual, 0.54 ± 0.23 mm). Tissue thickness showed comparable values at both the buccal and lingual regions and was significantly improved in the studied groups (0.82–0.92 mm vs. 33–48 mm in the control group). Conclusions: Relative to the commercially available BLT-SLA active implants, BLT-SLA pre-treated with BBL showed improved histological and histomorphometric characteristics indicating a reduced titanium surface roughness and improved wettability, promoting healing and soft and hard tissue regeneration at the implant site. MDPI 2021-10-19 /pmc/articles/PMC8540508/ /pubmed/34683810 http://dx.doi.org/10.3390/ma14206217 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ferrés-Amat, Eduard
Al Madhoun, Ashraf
Ferrés-Amat, Elvira
Al Demour, Saddam
Ababneh, Mera A.
Ferrés-Padró, Eduard
Marti, Carles
Carrio, Neus
Barajas, Miguel
Atari, Maher
Histologic and Histomorphometric Evaluation of a New Bioactive Liquid BBL on Implant Surface: A Preclinical Study in Foxhound Dogs
title Histologic and Histomorphometric Evaluation of a New Bioactive Liquid BBL on Implant Surface: A Preclinical Study in Foxhound Dogs
title_full Histologic and Histomorphometric Evaluation of a New Bioactive Liquid BBL on Implant Surface: A Preclinical Study in Foxhound Dogs
title_fullStr Histologic and Histomorphometric Evaluation of a New Bioactive Liquid BBL on Implant Surface: A Preclinical Study in Foxhound Dogs
title_full_unstemmed Histologic and Histomorphometric Evaluation of a New Bioactive Liquid BBL on Implant Surface: A Preclinical Study in Foxhound Dogs
title_short Histologic and Histomorphometric Evaluation of a New Bioactive Liquid BBL on Implant Surface: A Preclinical Study in Foxhound Dogs
title_sort histologic and histomorphometric evaluation of a new bioactive liquid bbl on implant surface: a preclinical study in foxhound dogs
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540508/
https://www.ncbi.nlm.nih.gov/pubmed/34683810
http://dx.doi.org/10.3390/ma14206217
work_keys_str_mv AT ferresamateduard histologicandhistomorphometricevaluationofanewbioactiveliquidbblonimplantsurfaceapreclinicalstudyinfoxhounddogs
AT almadhounashraf histologicandhistomorphometricevaluationofanewbioactiveliquidbblonimplantsurfaceapreclinicalstudyinfoxhounddogs
AT ferresamatelvira histologicandhistomorphometricevaluationofanewbioactiveliquidbblonimplantsurfaceapreclinicalstudyinfoxhounddogs
AT aldemoursaddam histologicandhistomorphometricevaluationofanewbioactiveliquidbblonimplantsurfaceapreclinicalstudyinfoxhounddogs
AT ababnehmeraa histologicandhistomorphometricevaluationofanewbioactiveliquidbblonimplantsurfaceapreclinicalstudyinfoxhounddogs
AT ferrespadroeduard histologicandhistomorphometricevaluationofanewbioactiveliquidbblonimplantsurfaceapreclinicalstudyinfoxhounddogs
AT marticarles histologicandhistomorphometricevaluationofanewbioactiveliquidbblonimplantsurfaceapreclinicalstudyinfoxhounddogs
AT carrioneus histologicandhistomorphometricevaluationofanewbioactiveliquidbblonimplantsurfaceapreclinicalstudyinfoxhounddogs
AT barajasmiguel histologicandhistomorphometricevaluationofanewbioactiveliquidbblonimplantsurfaceapreclinicalstudyinfoxhounddogs
AT atarimaher histologicandhistomorphometricevaluationofanewbioactiveliquidbblonimplantsurfaceapreclinicalstudyinfoxhounddogs